Atezolizumab vs Osimertinib Mesylate

## Atezolizumab vs Osimertinib Mesylate: Overview

This comparison examines the pharmacological differences between **Atezolizumab** and **Osimertinib Mesylate**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Atezolizumab — 27 days; Osimertinib Mesylate — N/A.

## Chemical Properties

**Type**: Atezolizumab — Antibody; Osimertinib Mesylate — Small molecule.